Related Experiment Videos
Hypokinesia in Huntington's disease
J P van Vugt1, B J van Hilten, R A Roos
1Department of Neurology, Leiden University Hospital, The Netherlands.
Summary
Huntington's disease patients exhibit reduced daytime motor activity, a condition known as hypokinesia. This hypokinesia is exacerbated by neuroleptic drug use and correlates with functional disability.
Area of Science:
- Neurology
- Movement Disorders
- Neuroscience
Background:
- Huntington's disease (HD) is a progressive neurodegenerative disorder.
- Motor symptoms in HD are typically characterized by chorea (involuntary movements), but hypokinesia (reduced movement) may also occur.
- The impact of neuroleptic medications on motor activity in HD is not fully understood.
Purpose of the Study:
- To quantitatively assess motor activity in patients with Huntington's disease.
- To investigate the relationship between motor activity, neuroleptic drug use, and clinical features in HD.
- To determine if hypokinesia or hyperkinesia is the predominant motor activity pattern in HD.
Main Methods:
- Quantitative motor activity assessment using wrist-worn activity monitors over 5 days.
- Inclusion of 14 patients with Huntington's disease and 14 age/sex-matched healthy controls.
- Clinical assessments including dementia, depression, motor impairment, chorea, and disability ratings.
Main Results:
- Patients with Huntington's disease showed significantly decreased daytime motor activity compared to controls, indicating hypokinesia.
- Hypokinesia was more pronounced in HD patients using neuroleptic drugs.
- Lower motor activity levels correlated significantly with lower functional disability scores.
Conclusions:
- Hypokinesia is a prominent motor manifestation in Huntington's disease.
- Neuroleptic drug use appears to worsen hypokinesia in HD patients.
- Reduced motor activity in HD is linked to functional disability.